Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease

DNA and Cell Biology

Volumn 20, Issue 11, 2001, Pages 697-703

  Solomon, Beka ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; ANTIGEN; CHAPERONE; EPITOPE; MONOCLONAL ANTIBODY; PEPTIDE; VACCINE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; AMNESIA; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIOPHAGE; CENTRAL NERVOUS SYSTEM; CORRELATION FUNCTION; DEMENTIA; DISEASE SEVERITY; IMMUNIZATION; IMMUNOLOGICAL PROCEDURES; IMMUNOTHERAPY; IN VITRO STUDY; LEARNING DISORDER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; THERMODYNAMICS; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; DISEASE MODELS, ANIMAL; EPITOPES; HUMANS; IMMUNOTHERAPY; MICE; MICE, TRANSGENIC;

MUS MUSCULUS;

EID: 0035695315     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/10445490152717550     Document Type: Article

References (58)

1. Peripherally administered antibodies against amyloid beta peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
2. Protective immune responses induced by the immunization of mice with recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus
3. Solution structures of β-peptide and its constituent fragments: Relation to amyloid deposition
4. Partly native epitopes are already present on early intermediates in the folding of tryptophan synthase
5. Antibody assisted protein refolding
6. Conformational disease
7. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
8. Biochemistry of Alzheimer's disease, amyloid plaques
9. Temperature dependent X-ray diffraction as a probe of protein structural dynamics
10. N-terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregating antibodies
11. High affinity binding of monoclonal antibodies to the sequential epitope EFRH of β-amyloid peptide is essential for modulation of fibrillar aggregation
12. Modulation of Alzheimer's beta-amyloid neurotoxicity by site-directed single-chain antibody
13. Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration
14. Generation of auto-antibodies towards Alzheimer's disease vaccination
15. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
16. Multiple display of foreign peptides on a filamentous bacteriophage
17. Inhibitory effect of monoclonal antibodies on Alzheimer's β-amyloid peptide aggregation
18. Amyloid, the presenilins and Alzheimer's disease
19. Amyloid deposition as the central event in the aetiology of Alzheimer's disease
20. Genetic dissection of Alzheimer's disease and related dementias: Amyloid and its relationship to tau
21. Is amyloid deposition in Alzheimer's disease preceded by an environment induced double conformational transition?
22. Antibody phage display technology and its applications
23. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide
24. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
25. Molecular dynamics simulations in biology
26. Effect of monoclonal antibodies in preventing carboxypeptidase A aggregation
27. Alternative conformations of amyloidogenic proteins govern their behavior
28. pH-dependent conformations of the amyloid β (1-28) peptide fragment explored using molecular dynamics
29. Candidate gene for the chromosome 1 familial Alzheimer's disease locus
30. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
31. Brain amyloid - A physicochemical perspective
32. Phage display: All dressed up and ready to role
33. Derivation of vaccines from mimotopes: Immunological properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage
34. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
35. High level neuronal expression of Aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
36. Loss of olfactory function in dementing disease
37. Aminoterminal deletions enhance aggregation of β-amyloid peptides in vitro
38. Immunization with amyloid-β attenuates Alzheimer's disease-like pathology in the PDAPP mouse
39. Discovering peptide ligands using epitope libraries
40. Searching for peptide ligands with an epitope library
41. The molecular pathology of Alzheimer's disease
42. Amyloid β-protein and the genetics of Alzheimer's disease
43. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
44. The x-yltic protease pro-region does not require a physical linkage to activate the protease domain in vivo
45. An improved MTT assay
46. Thermostabilization of carboxypeptidase A by interaction with its monoclonal antibodies
47. Vaccination for the prevention and treatment of Alzheimer's disease
48. Chaperone-like effect of monoclonal antibodies on refolding of heat-denatured carboxypeptidase A
49. Disaggregation of Alzheimer beta-amyloid by site-directed mAb
50. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer's βamyloid peptide
51. Alzheimer's and prion disease as disorders of protein conformation: Implications for the design of novel therapeutic approaches
52. The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation
53. Defective protein folding as a basis of human disease
54. Single and multiple transgenic mice as models for Alzheimer's disease
55. Mutations and off-pathway aggregation of proteins
56. Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage
57. Making antibody by phage display technology
58. Oral anti-IgE immunization with epitope-displaying phage